Optiscan on mission to revolutionise medical imaging
Posted: 9 June 2023 ASX-listed Optiscan Imaging is ramping up its bid to pioneer a new standard of care in digital pathology and precision surgery, with its biopsy-free, slide-free, non-invasive, live single-cell medical imaging technology. The company’s patented…
BioMelbourne Network and Wilam welcome CAI as foundational corporate partner
Posted: 8 June 2023 BioMelbourne Network’s digital transformation strategy is designed to change how our sector connects, strengthens and grows, to “reimagine engagement”. In November 2022, we launched Wilam, our Life…
Abstract & poster highlighting positive clinical results for ColoSTAT® Poster Presentation at ASCO Annual Meeting
Posted: 7 June 2023 Transformative cancer diagnostics technology company Rhythm Biosciences Ltd (ASX: RHY) (Rhythm or the Company) is pleased to announce that the abstract detailing the main results from the clinical trial for ColoSTAT®, its simple blood…
VIRALEZE Nasal Spray Approved in Malaysia
Posted: 6 June 2023 Starpharma today announces that it has achieved regulatory approval for its antiviral nasal spray product, VIRALEZE™, in Malaysia. The registration will allow Starpharma and its commercial partners to market and sell the product in Malaysia,…
Unlocking the Mystery of Brain Function and Connectivity
Posted: 5 June 2023 The science of this game-changing Monash-led research is complicated. But also, in the end, pretty simple. The shape of your brain is much more important than scientists have previously thought, learning now that how…
Peter Mac Scientists Discover Fundamental Breakthrough in Liver Cancer Development
Posted: 5 June 2023 New Peter Mac research recently published in Proceedings of the National Academy of Sciences (PNAS) has discovered a fundamental breakthrough related to the development of liver cancer The research team, led by Dr Andrew…
Improving Outcomes for Brain Cancer Patients
Posted: 5 June 2023 Despite our best research efforts, outcomes for most brain cancer have not improved significantly over the last 30 years but Dr Jim Whittle believes that is about to change. Dr Whittle, a medical oncologist…
Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment
Posted: 1 June 2023 Firebrick Pharma is pleased to provide an update on the progress of the confirmatory Phase 3 clinical trial of Nasodine Nasal Spray as a treatment for the common cold. The study, which commences in…
Optiscan Launches Entitlement Offer to Raise $16.7M
Posted: 1 June 2023 Optiscan Imaging Limited (ASX: OIL) is pleased to announce that it has lodged a prospectus with ASIC (Prospectus) in respect of a pro rata entitlement offer of one (1) fully paid ordinary share (Share)…
Incisive Technologies announces the US FDA has issued 510K clearance for BlueCheck Caries Detection and Monitoring
Posted: 30 May 2023 Incisive Technologies announces the US Food and Drug Administration (FDA) has issued 510K clearance for BlueCheck™ Caries Detection and Monitoring, a novel caries detection device used by clinicians in dental examinations to aid the…
4DMedical completes oversubscribed $25m Securities Purchase Plan
Posted: 30 May 2023 Respiratory imaging technology company, 4DMedical Limited (ASX:4DX, “4DMedical” or the “Company”) is pleased to announce the successful completion of its SPP. Strong support was received from 1,129 Eligible Shareholders, out of a total of…
Stellar scientists join the Australian Academy of Science
Posted: 30 May 2023 Professor Sharon Lewin AO and Professor Andrew Wilks have been elected as 2023 Fellows of The Australian Academy of Science. They join 18 other researchers and scientists this year, nominated by peers for their…
